Brain and Spinal Tumors Incidence Annual Audit 2017 of Dept of Neurosurgery Khoula Hospital Muscat Oman: A Review

G P Mishra¹, Tariq Al Saadi¹, Neeraj Salhotra^1, , Samit Biniwale¹, Mohammad Hadad¹, Mohammad Hashim¹, Ali Al Mashani¹, Qassim Al Hinai¹ and Sharad Samson Rajmani¹

¹Department of Neurosurgery Khoula Hospital Muscat Oman PO 90, PC 116

Cite this paper:
G P Mishra, Tariq Al Saadi, Neeraj Salhotra, Samit Biniwale, Mohammad Hadad, Mohammad Hashim, Ali Al Mashani, Qassim Al Hinai and Sharad Samson Rajmani. Brain and Spinal Tumors Incidence Annual Audit 2017 of Dept of Neurosurgery Khoula Hospital Muscat Oman: A Review. American Journal of Medical Case Reports. 2018; 6(7):128-131. doi: 10.12691/ajmcr-6-7-2

Abstract

Brain and spinal tumors contribute to the main bulk of neurosurgery work in any Neurosurgical center. Effective audit of the work of a neurosurgical center amounts to earmarking the areas needing improvement and hence an enhanced patient care. Our department also performed an annual audit of the cranial and spinal tumors dealt in one year and analyzed the results. Benign to malignant all varieties of cranial tumours were seen in a small population of a country like Oman, however state of art diagnostic facilities were used to diagnose, treat and follow up the patients. Careful eye was kept on the pseudoprogression of the tumours as repted in the radiological reports. Results revealed a standard distribution of the tumours seen in other centers reported in the literature. Extent of tumour excision was done in standard guidelines keeping patient useful outcome in mind. Resurgery in maligant tumours were offered in young patients if comes back with recurrence.

Keywords:
Brain and spinal tumors incidence pseudopogression of tumours

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Chang-Hyun Lee, M.D., Kyu-Won Jung, M.S., Heon Yoo, M.D., Ph.D., Sohee Park, Ph.D., and Seung Hoon Lee, M.D. Epidemiology of Primary Brain and Central Nervous System Tumors in Korea. Korean Neurosurg Soc. 2010 Aug; 48(2): 145-152. Published online 2010 Aug 31.
[2]	Vastrad B, Vastrad C, Godavarthi A, Chandrashekar R. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data. Med Oncol. 2017 Sep 26; 34(11): 182.
[3]	Lijuan Bo, Bo Wei, Chaohui Li, Zhan feng Wang, Zheng Gao, and Zhuang Miao. Identification of potential key genes associated with glioblastoma based on the gene expression profile. OncolLett. 2017 Aug; 14(2): 2045-2052.
[4]	CJ, Altschuler G, Jeong J, Strømme KK, Stangeland B, Murrell W, Grasmo-Wendler UH, Myklebost O, Helseth E, Vik-Mo EO, Hide W, Langmoen IA. Comparison of glioma stem cells to neural stem cells from the adult human brain identifies dysregulated Wnt-signaling and a fingerprint associated with clinical outcomeSandberg. Exp Cell Res. 2013 Aug 15; 319(14): 2230-43.
[5]	AGHAYAN GOLKASHANI, MD, Hossein HATAMI, MD, MPH , Abdonaser FARZAN, MD, Hassan Reza MOHAMMADI, MD, Yalda NILIPOUR, MD, Maliheh KHODDAMI, MDandFarzaneh JADALI, MD. Tumors of the Central Nervous System: An 18-Year Retrospective Review in a Tertiary Pediatric Referral CenterHosein. Iran J Child Neurol. 2015 Summer; 9(3): 24-33.
[6]	Chu TPC, Shah A, Walker D, Coleman MP. How Do Biological Characteristics of Primary Intracranial Tumors Affect Their Clinical Presentation in Children and Young Adults? J Child Neurol. 2018 Jan 1:883073818767562.
[7]	Chu TP, Shah A, Walker D, Coleman MP. Where are the opportunities for an earlier diagnosis of primary intracranial tumours in children and young adults? Eur J Paediatr Neurol. 2017 Mar; 21(2): 388-395.
[8]	Thust SC, van den Bent MJ, Smits M. Pseudoprogression of brain tumors. J Magn Reson Imaging. 2018 May 7.
[9]	Liu ZC, Yan LF, Hu YC, Sun YZ, Tian Q, Nan HY, Yu Y, Sun Q, Wang W, Cui GB. Combination of IVIM-DWI and 3D-ASL for differentiating true progression from pseudoprogression of Glioblastomamultiforme after concurrent chemoradiotherapy: study protocol of a prospective diagnostic trial. BMC Med Imaging. 2017 Feb 1; 17(1): 10.
[10]	Choi YJ, Kim HS, Jahng GH, Kim SJ, Suh DC. Pseudoprogression in patients with glioblastoma: added value of arterial spin labeling to dynamic susceptibility contrast perfusion MR imaging. Acta Radiol. 2013 May; 54(4): 448-54.